Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Feb 29, 2024, after the close
10-K filed Feb 29, 2024, 60 days after period end · 0000320017-24-000007
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$5.37M |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$5.99M |
| -$6.79M |
| -$5.43M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
